Jellyana Peraza, MD
Assistant ProfessorCards
About
Research
Publications
2026
Automating clinical phenotyping using natural language processing
Schmidt L, Ibing S, Borchert F, Hugo J, Marshall A, Peraza J, Cho J, Böttinger E, Renard B, Ungaro R. Automating clinical phenotyping using natural language processing. Communications Medicine 2026, 6: 77. PMID: 41530528, PMCID: PMC12873203, DOI: 10.1038/s43856-025-01337-0.Peer-Reviewed Original Research
2025
Statin Use is Associated With Lower Odds of IBD-Related Surgery Among Patients With Moderate-to-Severe Inflammatory Bowel Disease
Claytor J, Rajauria P, Peraza J, Colombel J, Ungaro R. Statin Use is Associated With Lower Odds of IBD-Related Surgery Among Patients With Moderate-to-Severe Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2025, 32: 253-260. PMID: 41418331, PMCID: PMC12857421, DOI: 10.1093/ibd/izaf227.Peer-Reviewed Original ResearchMild Crohn’s Disease Is Associated With Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation
Bourgonje A, Ibing S, Rajauria P, Peraza J, Consortium T, Ananthakrishnan A, Argmann C, Dubinsky M, Jacobsen H, Jess T, Larsen L, Renard B, Sands B, Shah S, Shapiro J, Suarez-Fariñas M, Colombel J, Ungaro R. Mild Crohn’s Disease Is Associated With Altered Sphingolipid Metabolism and Reduced Neutrophilic Inflammation. Gastroenterology 2025, 169: 1294-1297. PMID: 40701397, DOI: 10.1053/j.gastro.2025.06.026.Peer-Reviewed Original ResearchA Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression
Peraza J, Kaper M, Bargas A, Kim I, Agrawal M, Larsen L, Jacobsen H, Jess T, Colombel J, Torres J, Ungaro R, Ananthakrishnan A. A Simple Endoscopic Score for Crohn's Disease (SES‐CD) ≥ 7 Predicts Disease Progression. Alimentary Pharmacology & Therapeutics 2025, 61: 1011-1018. PMID: 39757503, PMCID: PMC11870798, DOI: 10.1111/apt.18492.Peer-Reviewed Original Research
2024
Disparities in Gender and Race Representation Among Authors of Inflammatory Bowel Disease Clinical Trials
Gros B, Peraza J, Bassi M, Sleiman J, Abdelhalim S, Park E, Wong S, Agrawal M, Grinspan L, Charabaty A. Disparities in Gender and Race Representation Among Authors of Inflammatory Bowel Disease Clinical Trials. Journal Of Crohn's And Colitis 2024, 19: jjae184. PMID: 39657593, PMCID: PMC13031988, DOI: 10.1093/ecco-jcc/jjae184.Peer-Reviewed Original ResearchManagement of Overweight and Obesity in Patients With Inflammatory Bowel Disease.
Shneyderman M, Freid H, Kohler D, Peraza J, Haskey N, Abbott E, Kornbluth A, Raman M, Gold S. Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease. Gastroenterology & Hepatology 2024, 20: 712-722. PMID: 39886003, PMCID: PMC11776002.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsThe Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease
Peraza J, Abbott E, Shneyderman M, Kornbluth A, Raman M, Gold S. The Rising Epidemic of Obesity in Patients with Inflammatory Bowel Disease. Current Treatment Options In Gastroenterology 2024, 22: 134-144. DOI: 10.1007/s11938-024-00453-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRisk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease
Greywoode R, Larson J, Peraza J, Clark R, Allison M, Chaudhry N, Schnatz P, Shadyab A, Wallace R, Wassertheil-Smoller S. Risk of Adverse Cardiovascular Outcomes in Postmenopausal Women with Inflammatory Bowel Disease. Digestive Diseases And Sciences 2024, 69: 2586-2594. PMID: 38684633, PMCID: PMC11258184, DOI: 10.1007/s10620-024-08348-2.Peer-Reviewed Original Research
2023
Do We Need AI to Diagnose AI? Diagnosis and Management of Adrenal Insufficiency Following Steroid Therapy in a Patient with Inflammatory Bowel Disease
Law C, Peraza J, Viera Feliciano N, Ungaro R, Cheesman K, Colombel J, Livanos A. Do We Need AI to Diagnose AI? Diagnosis and Management of Adrenal Insufficiency Following Steroid Therapy in a Patient with Inflammatory Bowel Disease. Digestive Diseases And Sciences 2023, 68: 4327-4330. PMID: 37831398, DOI: 10.1007/s10620-023-08123-9.Peer-Reviewed Original Research
2022
One Step Forward, Two Steps Back? Disproportionate Loss of Scientific Productivity With Long-Term Effects Among Women and Caregivers During the Pandemic
Wong S, Peraza J, Grinspan L, Agrawal M. One Step Forward, Two Steps Back? Disproportionate Loss of Scientific Productivity With Long-Term Effects Among Women and Caregivers During the Pandemic. Gastroenterology 2022, 162: 2125-2126. PMID: 35358507, DOI: 10.1053/j.gastro.2022.03.038.Commentaries, Editorials and Letters
Academic Achievements & Community Involvement
Teaching & Mentoring
Clinical Care
Overview
Jellyana Peraza, MD, is a gastroenterologist who specializes in the treatment of digestive disorders, particularly inflammatory bowel disease (IBD). She focuses on identifying and managing conditions such as Crohn’s disease and ulcerative colitis, helping patients alleviate symptoms and enhance quality of life.
As an assistant professor at Yale School of Medicine, Dr. Peraza is involved in research aimed at improving the understanding and treatment of gastrointestinal diseases.
Dr. Peraza received her medical training from the Universidad Central de Venezuela. She completed her residency and served as chief resident in internal medicine at Montefiore Medical Center, and pursued her fellowship in gastroenterology at the Icahn School of Medicine at Mount Sinai.
Clinical Specialties
Gastroenterology; Inflammatory Bowel Disease
News
Get In Touch
Contacts
Appointment Number
Clinic Fax Number
Mailing Address
Yale School of Medicine
Department of Medicine (Digestive Diseases), P.O. Box 208019
New Haven, Connecticut 06520-8019
United States
Administrative Support
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.